Fisher Asset Management
KRYS icon

Fisher Asset Management’s Krystal Biotech KRYS Stock Holding History

Fisher Asset Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Sell
27,676
-108
-0.4% -$32.3K ﹤0.01% 408
2026
Q1 		$7.18M Buy
27,784
+23,998
+634% +$6.39M ﹤0.01% 427
2025
Q4 		$933K Buy
+3,786
New +$797K ﹤0.01% 683
2023
Q2 		– Sell
-29
Closed -$2.32K – 1190
2023
Q1 		$2.32K Buy
+29
New +$2.28K ﹤0.01% 1098

Other funds holding KRYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Fisher Asset Management's KRYS Position: Q2 2026 in Review

Fisher Asset Management reduced its Krystal Biotech (KRYS) stake by 0.39% in Q2 2026, selling an estimated $32.3K and leaving 27,676 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #408.

Fisher Asset Management first reported a position in KRYS in Q1 2023 and has held it in 4 quarters since. 191 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Fisher Asset Management held 27,676 shares of Krystal Biotech worth $10.3M as of Q2 2026.
  • Fisher Asset Management sold 108 Krystal Biotech shares in Q2 2026, an estimated $32.3K.
  • Krystal Biotech made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #408 holding.
  • Fisher Asset Management first reported a position in Krystal Biotech in Q1 2023 and has held it in 4 quarters since.
  • 191 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.